| 000 | 01531 a2200433 4500 | ||
|---|---|---|---|
| 005 | 20250517174018.0 | ||
| 264 | 0 | _c20180629 | |
| 008 | 201806s 0 0 eng d | ||
| 022 | _a1520-6017 | ||
| 024 | 7 |
_a10.1016/j.xphs.2017.08.024 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWavikar, Preeti | |
| 245 | 0 | 0 |
_aNose to Brain Delivery of Rivastigmine by In Situ Gelling Cationic Nanostructured Lipid Carriers: Enhanced Brain Distribution and Pharmacodynamics. _h[electronic resource] |
| 260 |
_bJournal of pharmaceutical sciences _c12 2017 |
||
| 300 |
_a3613-3622 p. _bdigital |
||
| 500 | _aPublication Type: Journal Article | ||
| 650 | 0 | 4 |
_aAdministration, Intranasal _xmethods |
| 650 | 0 | 4 | _aAnimals |
| 650 | 0 | 4 |
_aBlood-Brain Barrier _xmetabolism |
| 650 | 0 | 4 |
_aBrain _xmetabolism |
| 650 | 0 | 4 |
_aCations _xchemistry |
| 650 | 0 | 4 |
_aDrug Carriers _xchemistry |
| 650 | 0 | 4 |
_aDrug Delivery Systems _xmethods |
| 650 | 0 | 4 |
_aGels _xchemistry |
| 650 | 0 | 4 |
_aLipids _xchemistry |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aMice |
| 650 | 0 | 4 |
_aNanostructures _xchemistry |
| 650 | 0 | 4 |
_aNasal Mucosa _xmetabolism |
| 650 | 0 | 4 | _aParticle Size |
| 650 | 0 | 4 | _aRats |
| 650 | 0 | 4 | _aRats, Wistar |
| 650 | 0 | 4 |
_aRivastigmine _xadministration & dosage |
| 650 | 0 | 4 |
_aTissue Distribution _xdrug effects |
| 700 | 1 | _aPai, Rohan | |
| 700 | 1 | _aVavia, Pradeep | |
| 773 | 0 |
_tJournal of pharmaceutical sciences _gvol. 106 _gno. 12 _gp. 3613-3622 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1016/j.xphs.2017.08.024 _zAvailable from publisher's website |
| 999 |
_c27577946 _d27577946 |
||